Page last updated: 2024-08-25

bindarit and trinitrobenzenesulfonic acid

bindarit has been researched along with trinitrobenzenesulfonic acid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Basta, F; Bhatia, M; Bovi, G; de Joannon, AC; Guglielmotti, A; Landolfi, C; Ramnath, RD	1

Other Studies

1 other study(ies) available for bindarit and trinitrobenzenesulfonic acid

Article	Year
Treatment with bindarit, an inhibitor of MCP-1 synthesis, protects mice against trinitrobenzene sulfonic acid-induced colitis. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2008, Volume: 57, Issue:10 Topics: Animals; Cells, Cultured; Chemokine CCL2; Colitis; Disease Progression; Epithelial Cells; Female; Humans; Indazoles; Interferon-gamma; Mice; Mice, Inbred BALB C; Propionates; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2008

Article

Year

Treatment with bindarit, an inhibitor of MCP-1 synthesis, protects mice against trinitrobenzene sulfonic acid-induced colitis.

Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2008, Volume: 57, Issue:10

Topics: Animals; Cells, Cultured; Chemokine CCL2; Colitis; Disease Progression; Epithelial Cells; Female; Humans; Indazoles; Interferon-gamma; Mice; Mice, Inbred BALB C; Propionates; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

2008